Search Within

Ann Jakubowski

Formats
  1. Meeting Abstract (247)
  2. Journal Article (194)
  3. Research Letter (7)
  4. Review (4)
  5. Book Section (3)
  6. Conference Paper (2)
  7. Correspondence (1)
Groups
  1. Bone Marrow Transplant (458)
  2. Center for Hematologic Malignancies (458)
  3. Department of Medicine (458)
  4. Hematologic Malignancies, Division of (458)
  5. Survivorship Research (458)
  6. Sloan Kettering Institute Faculty (190)

More Groups

People
  1. Esperanza Papadopoulos (255)
  2. Miguel-Angel Perales (247)
  3. Sergio Giralt (241)
  4. Hugo Castro-Malaspina (185)
  5. James Young (154)
  6. Richard O'Reilly (145)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (14)
  4. 2022 (18)
  5. 2021 (17)
  6. 2020 (25)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (150)
  2. Blood (118)
  3. Bone Marrow Transplantation (42)
  4. Blood Advances (12)
  5. Leukemia and Lymphoma (11)
  6. Transplantation and Cellular Therapy (11)

More Publications

Publishers
  1. Elsevier Inc. (164)
  2. American Society of Hematology (130)
  3. Nature Publishing Group (44)
  4. Wiley Blackwell (13)
  5. Oxford University Press (11)
  6. Taylor & Francis Group (11)

More Publishers

Results (458)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PCR screening for Epstein-Barr virus-related Lymphoproliferative disease (EBV-LPD) among allogeneic stem cell transplant (AlloSCT) recipients: The importance of T cell depletion
    Meeting Abstract

    Ambrossi, G. G.; Jakubowski, A.; Brennan, C.; Kiehn, T. E.; Weinstock, D. M.
    Blood (2005)

    Fulltext@MSK | Save
  • Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer
    Journal Article

    Hurria, A.; Brogan, K.; Panageas, K. S.; Pearce, C.; Norton, L.; Jakubowski, A.; Howard, J.; Hudis, C.
    Drugs & Aging (2005)

    Fulltext@MSK | Save
  • Developing a cancer-specific geriatric assessment: A feasibility study
    Journal Article

    Hurria, A.; Gupta, S.; Zauderer, M.; Zuckerman, E. L.; Cohen, H. J.; Muss, H.; Rodin, M.; Panageas, K. S.; Holland, J. C.; Saltz, L.; more...
    Cancer (2005)

    Fulltext@MSK | Save
  • Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy
    Journal Article

    Hurria, A.; Brogan, K.; Panageas, K. S.; Pearce, C.; Norton, L.; Jakubowski, A.; Zauderer, M.; Howard, J.; Hudis, C.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy
    Journal Article

    Hurria, A.; Brogan, K.; Panageas, K. S.; Jakubowski, A.; Zauderer, M.; Pearce, C.; Norton, L.; Howard, J.; Hudis, C.
    Drugs & Aging (2005)

    Fulltext@MSK | Save
  • Active tuberculosis limited to foreign-born patients after allogeneic hematopoietic stem cell transplant - Correspondence
    Journal Article

    Garces Ambrossi, G.; Jakubowski, A.; Feinstein, M. B.; Weinstock, D. M.
    Bone Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients
    Journal Article

    Almyroudis, N. G. ; Fuller, A.; Jakubowski, A.; Sepkowitz, K.; Jaffe, D.; Small, T. N.; Kiehn, T. E.; Pamer, E.; Papanicolaou, G. A.
    Transplant Infectious Disease (2005)

    Fulltext@MSK | Save
  • Growth potential of human leukemia blast cells in SCID mice and association with prognosis of human acute leukemias
    Meeting Abstract

    Yan, Y.; Steinherz, P.; Guan, X. Q.; Jakubowski, A.; McGuirk, J. P.; O'Reilly, R. J.
    Blood (2004)

    Fulltext@MSK | Save
  • Vaccine reponses following unmodified or T cell depleted unrelated and mismatched related HCT
    Meeting Abstract

    Small, T. N.; Papadopoulos, E. B.; Boulad, F.; Kernan, N. A.; Ford, R.; Taylor, J.; Casson, A.; Torok-Castanza, J.; Cuello, B.; Young, J. W.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • A phase II trial of a non-myeloablative regimen combining in vivo T cell depletion with an anti-CD52 monoclonal antibody (alemtuzumab), and chemotherapy with fludarabine and melphalan prior to a related or unrelated hematopoietic stem cell transplantation
    Meeting Abstract

    Castro-Malaspina, H.; Papadopoulos, E.; Jakubowski, A.; Perales, M. A.; Young, J.; Hsu, K.; Boulad, F.; Prasad, V.; Small, T.; Kernan, N.; more...
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save